Life Sciences Horizons Brochure 2025 - Flipbook - Page 52
2025 Horizons Life Sciences and Health Care
Transactions.
51
7
Click on a section to take you to the relevant page
52
Amid regulatory uncertainty, medical device
mergers & acquisitions show promise in 2025
53
Pharmaceutical antitrust enforcement under
new U.S. and EU leadership
54
Health care joint ventures: Navigating
antitrust risk in a void of guidance
55
Private health care investments in France: First
responses to growing financialization
56
China licensing transactions checklist
57
How to navigate demergers in China
